Anthony Defino

The FDA granted orphan drug designation to OpCT-001 for the treatment of retinitis pigmentosa, according to a press release from BlueRock Therapeutics.The investigational induced pluripotent stem cell-derived cell therapy is currently being evaluated in the phase 1/2a CLARICO study.

The FDA approved a new drug application labeling supplement that allows readministration of iDose TR with a repeat treatment protocol, according to a press release from Glaukos.

WAIKOLOA, Hawaii — A study found that Qlosi demonstrated positive pupil diameter reductions without yielding significant changes in ciliary muscle response, according to a speaker at Hawaiian Eye 2026. In a presentation, Florence Cabot, MD, of Bascom Palmer Eye Institute in Miami, shared data that compared the impact of Qlosi (pilocarpine hydrochloride ophthalmic solution 0.4%, Orasis

When building a career as a young ophthalmologist, there are no rules or set paths.In the inaugural episode of Steeped Insights, a video blog series produced by Women in Ophthalmology and Healio, host Karen Chen, MD, of The Permanente Medical Group, and cohost Andrea L. Kossler, MD, FACS, of Stanford University and Byers Eye Institute, sat down with Andrea Tooley, MD, of Mayo Clinic. Over a cup

WASHINGTON— Financial success for every branch of ophthalmology requires all three pillars of the specialty to work collaboratively to find practical solutions, according to a speaker at SightLine. American Society of Cataract and Refractive Surgery executive director Steve Speares identified the three major stakeholders in ophthalmology as surgeons, administrators and industry

For a fulfilling career in ophthalmology, find the right cultural fit during every step of the journey, from training to residency and beyond.

WASHINGTON — A technology introduced at the American Society of Cataract and Refractive Surgery meeting has shown promise in addressing an unmet need in glaucoma surgery, according to a presenter. During the Charles D. Kelman, MD, Innovator’s Lecture, Sean Ianchulev, MD, MPH, said that while cataract surgery has had a success rate of about 95% for the past 50 years, the success rate of

DENVER — Despite challenges for approval and access, regenerative therapies for retinal diseases may not be far away from becoming viable treatment options, according to a panel discussion at Eyecelerator@ARVO. Allen C. Ho, MD, who co-moderated the panel, told Healio that there are still unmet needs from a patient perspective for those with retinal degenerations, even with approved

DENVER — MCO-010, an optogenetic therapy, demonstrated vision improvements for patients with retinitis pigmentosa at 3 years, according to a presenter at the Association for Research in Vision and Ophthalmology meeting. Optogenetic treatment for retinal disease focuses on restoring light sensitivity to retinal cells through the delivery of synthetic protein, Vinit B. Mahajan, MD, PhD, a retina

Systemic statin use reduced the rate of proliferative vitreoretinopathy and reoperation following primary retinal detachment repair by nearly half, according to a speaker at the American Society of Retina Specialists annual meeting.